| abstract |
The present invention relates to phosphonic acid-containing T3-like agents and monoesters, stereoisomers, pharmaceutically acceptable salts, co-crystals, and prodrugs thereof, and pharmaceutically acceptable salts and co-crystals of the prodrugs. Their production, and also metabolic diseases such as obesity, NASH, hypercholesterolemia and hyperlipidemia and related conditions such as atherosclerosis, coronary heart disease, impaired glucose tolerance, metabolic syndrome X and diabetes Relates to their use for preventing and / or treating. |